333 related articles for article (PubMed ID: 10192780)
1. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.
Sieradzan KA; Mechan AO; Jones L; Wanker EE; Nukina N; Mann DM
Exp Neurol; 1999 Mar; 156(1):92-9. PubMed ID: 10192780
[TBL] [Abstract][Full Text] [Related]
2. Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease.
Sapp E; Penney J; Young A; Aronin N; Vonsattel JP; DiFiglia M
J Neuropathol Exp Neurol; 1999 Feb; 58(2):165-73. PubMed ID: 10029099
[TBL] [Abstract][Full Text] [Related]
3. The selective vulnerability of nerve cells in Huntington's disease.
Sieradzan KA; Mann DM
Neuropathol Appl Neurobiol; 2001 Feb; 27(1):1-21. PubMed ID: 11298997
[TBL] [Abstract][Full Text] [Related]
4. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length.
Becher MW; Kotzuk JA; Sharp AH; Davies SW; Bates GP; Price DL; Ross CA
Neurobiol Dis; 1998 Apr; 4(6):387-97. PubMed ID: 9666478
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
[TBL] [Abstract][Full Text] [Related]
6. Huntington aggregates may not predict neuronal death in Huntington's disease.
Kuemmerle S; Gutekunst CA; Klein AM; Li XJ; Li SH; Beal MF; Hersch SM; Ferrante RJ
Ann Neurol; 1999 Dec; 46(6):842-9. PubMed ID: 10589536
[TBL] [Abstract][Full Text] [Related]
7. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice.
Lloret A; Dragileva E; Teed A; Espinola J; Fossale E; Gillis T; Lopez E; Myers RH; MacDonald ME; Wheeler VC
Hum Mol Genet; 2006 Jun; 15(12):2015-24. PubMed ID: 16687439
[TBL] [Abstract][Full Text] [Related]
8. Huntingtin localization in brains of normal and Huntington's disease patients.
Sapp E; Schwarz C; Chase K; Bhide PG; Young AB; Penney J; Vonsattel JP; Aronin N; DiFiglia M
Ann Neurol; 1997 Oct; 42(4):604-12. PubMed ID: 9382472
[TBL] [Abstract][Full Text] [Related]
9. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease.
Schwab C; Arai T; Hasegawa M; Yu S; McGeer PL
J Neuropathol Exp Neurol; 2008 Dec; 67(12):1159-65. PubMed ID: 19018245
[TBL] [Abstract][Full Text] [Related]
10. Purification of neuronal inclusions of patients with Huntington's disease reveals a broad range of N-terminal fragments of expanded huntingtin and insoluble polymers.
Hoffner G; Island ML; Djian P
J Neurochem; 2005 Oct; 95(1):125-36. PubMed ID: 16181417
[TBL] [Abstract][Full Text] [Related]
11. Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset.
Gourfinkel-An I; Cancel G; Duyckaerts C; Faucheux B; Hauw JJ; Trottier Y; Brice A; Agid Y; Hirsch EC
Neuroreport; 1998 Jun; 9(8):1823-6. PubMed ID: 9665608
[TBL] [Abstract][Full Text] [Related]
12. Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice.
Li H; Li SH; Yu ZX; Shelbourne P; Li XJ
J Neurosci; 2001 Nov; 21(21):8473-81. PubMed ID: 11606636
[TBL] [Abstract][Full Text] [Related]
13. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.
Cooper JK; Schilling G; Peters MF; Herring WJ; Sharp AH; Kaminsky Z; Masone J; Khan FA; Delanoy M; Borchelt DR; Dawson VL; Dawson TM; Ross CA
Hum Mol Genet; 1998 May; 7(5):783-90. PubMed ID: 9536081
[TBL] [Abstract][Full Text] [Related]
14. Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain.
Maat-Schieman ML; Dorsman JC; Smoor MA; Siesling S; Van Duinen SG; Verschuuren JJ; den Dunnen JT; Van Ommen GJ; Roos RA
J Neuropathol Exp Neurol; 1999 Feb; 58(2):129-37. PubMed ID: 10029096
[TBL] [Abstract][Full Text] [Related]
15. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
DiFiglia M; Sapp E; Chase KO; Davies SW; Bates GP; Vonsattel JP; Aronin N
Science; 1997 Sep; 277(5334):1990-3. PubMed ID: 9302293
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase cross-links in intranuclear inclusions in Huntington disease.
Zainelli GM; Ross CA; Troncoso JC; Muma NA
J Neuropathol Exp Neurol; 2003 Jan; 62(1):14-24. PubMed ID: 12528814
[TBL] [Abstract][Full Text] [Related]
17. Characterization of HTT inclusion size, location, and timing in the zQ175 mouse model of Huntington's disease: an in vivo high-content imaging study.
Carty N; Berson N; Tillack K; Thiede C; Scholz D; Kottig K; Sedaghat Y; Gabrysiak C; Yohrling G; von der Kammer H; Ebneth A; Mack V; Munoz-Sanjuan I; Kwak S
PLoS One; 2015; 10(4):e0123527. PubMed ID: 25859666
[TBL] [Abstract][Full Text] [Related]
18. A cellular model that recapitulates major pathogenic steps of Huntington's disease.
Lunkes A; Mandel JL
Hum Mol Genet; 1998 Sep; 7(9):1355-61. PubMed ID: 9700187
[TBL] [Abstract][Full Text] [Related]
19. Full length huntingtin is not detected in intranuclear inclusions in Huntington's disease brain.
Thomas P; Wilkinson F; Nguyen TM; Harper PS; Neal JW; Morris GE; Jones AL
Biochem Soc Trans; 1998 Aug; 26(3):S243. PubMed ID: 9765962
[No Abstract] [Full Text] [Related]
20. Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition.
Kim M; Lee HS; LaForet G; McIntyre C; Martin EJ; Chang P; Kim TW; Williams M; Reddy PH; Tagle D; Boyce FM; Won L; Heller A; Aronin N; DiFiglia M
J Neurosci; 1999 Feb; 19(3):964-73. PubMed ID: 9920660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
